Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 18, 2014
Pharmacy Choice - News - Over-the-Counter Drugs - September 18, 2014

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 9 of 9     Go To Page:

9/18/14 - Axxess Pharma to Launch Newest Innovation, All Natural, High Protein, Fat Burning, Ready to Drink (RTD), Protein Meal Replacement Within 15 Days
Axxess Pharma Inc., a specialty pharmaceutical and nutritional supplements company, is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., that their newest innovation, high protein, fat burning, Ready to Drink, protein meal replacement products will be available for retailers within 15 days. Axxess Pharma believes
9/18/14 - BASF supports the Sunscreen Innovation Act
FLORHAM PARK, NJ As a member of the Public Access to Sun Screens Coalition, BASF supports the Sunscreen Innovation Act, which today was approved by the Senate Committee on Health, Education, Labor and Pensions, led by Chairman Tom Harkin and Ranking Republican Lamar Alexander. "BASF commends the Senate HELP committee and Senators Jack Reed and J
9/18/14 - Biostar Pharmaceuticals, Inc. Files a PRC Patent Application for Oleanolic Acid Injection, its New Drug Product for Hepatitis B and Liver Cancer
XIANYANG, China, Sept. 18, 2014/ PRNewswire/ Biostar Pharmaceuticals, Inc., a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, announced today it has filed PRC national invention and creation patent for the pharmaceutical and preparation method of its new devel
9/18/14 - DGAP-News: Innovus Pharma Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+(TM) in the United Kingdom
DGAP-News: Innovus Pharmaceuticals, Inc. Innovus Pharma Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+ (TM) in the United Kingdom 18.09. 2014/ 12:15 Innovus Pharma Eligible to Receive Up to $44 Million in Sales M
9/18/14 - Innovus Pharma Signs Exclusive Marketing Sales and Distribution Agreement With Tramorgan Limited to Market and Distribute Sensum+(TM) in the United Kingdom
Innovus Pharmaceuticals, Inc., www.innovuspharma.com announced today that it has entered into an exclusive marketing and distribution agreement with Tramorgan Limited, a British company under which Innovus Pharma has granted to Tramorgan an exclusive marketing sales and distribution right to market and sell Innovus Pharma's topical consumer care.
9/17/14 - BASF Supports the Sunscreen Innovation Act
As a member of the Public Access to Sun Screens Coalition, BASF supports the Sunscreen Innovation Act, which today was approved by the Senate Committee on Health, Education, Labor and Pensions, led by Chairman Tom Harkin and Ranking Republican Lamar Alexander. "BASF commends the Senate HELP committee and Senators Jack Reed and Johnny Isakson for t
9/17/14 - Bel Marra Health Reports on New Benefits of Aspirin for Cancer Prevention
Bel Marra Health, who offers high-quality, specially formulated vitamins and nutritional supplements, has reported on new research which has outlined a potential use for aspirin: Cancer prevention. As Bel Marra Health reports in its article,, a new study indicates that long-term aspirin therapy may provide a strategy to protect against cancers of t
9/17/14 - BROWN-SPONSORED BILL TO EXPEDITE APPROVAL FOR SAFE SUNSCREEN INGREDIENTS CLEARS SENATE COMMITTEE
Ohio Companies BASF, L'Oreal, and Ashland Inc. Manufacture Safe Sunscreen Ingredients that Are Used in Canada and the EU but Have Been Awaiting FDA Approval for More than a Decade. WASHINGTON, D.C.- Legislation that would protect Ohioans from the effects of harmful exposure to the sun- including skin cancer- cleared the Senate Health, Education, La
9/15/14 - Consumer Healthcare Products Association Statement on Department of Justice's Action on Supplements Claims Standards
Release date- 12092014- Washington, D.C.- The Consumer Healthcare Products Association, the trade association representing the leading makers of over-the-counter medicines and dietary supplements, released the following statement today in response to the United States Department of Justice's decision to file a motion against Bayer for claims made i
Articles(s): 1 - 9 of 9     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

The Diversion of Controlled Substances and the Law
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415